November 12th, 2019
•We describe a quantitative real-time in vitro cytolysis assay system to evaluate the potency of chimeric antigen receptor T cells targeting liquid and solid tumor cells. This protocol can be extended to assess other immune effector cells, as well as combination treatments.
Tags
Video correlati
Retroviral Transduction of T-cell Receptors in Mouse T-cells
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Real-time Live Imaging of T-cell Signaling Complex Formation
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Highly Multiplexed, Super-resolution Imaging of T Cells Using madSTORM
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model